 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 2 | 1/1 | 返回列表 |
| 查看: 449 | 回復(fù): 1 | ||
[求助]
求助三段話翻譯
|
|
Local tolerance and sensitization studies External or histopathological evaluation of injection sites revealed no evidence of irritation in the singledose, repeated-dose or intermittent-dose studies. A tolerance study in rabbits used i.v. , paravenous p.v .; intradermal and intra-arterial (i.a.) administration of solutions of docetaxel in 0.9% aqueous NaCI containing polysorbate 80 at concentrations which were up to three times higher than those used in man; the results of this study indicated good tolerance by the i.a. and i.v. route and adequate tolerance by the p.v. route. Sensitization studies in mice, guinea pigs and rabbits revealed no evidence for sensitization, whereas a mild reaction was observed following intradermal re-challenge of docetaxel- pre-treated rabbits. In conclusion, the results of irritation and sensitization studies suggest a good tolerance and the absence of a signi白cant senslt1Za tion potential of the i. v. formulations of docetaxel Overall, the results of the preclinical toxicity studies indicate that the principal toxicological effects of docetaxel are compatible with the pharmacological (antimitotic) activity of the taxoid class of antineoplastic compounds.However,there were species-specific differences in the tolerance to the drug and in the susceptibility of principal target tissues. The results of the preclinical safety evaluations suggest that the monkey, in which hematopoietic effects (neutropenia) are the dose-limiting toxicity and in which i. v. administration of solutions containing polysorhate HO are well tolerated , may he the most suitahle large animal model for predicting the principal toxicities of docetaxel in man. The results of the acute toxicity study in dogs served as a hasis for the entry dose in man. Following recommendations of the :National Cancer Institute one third of the 'toxic dose low' in dogs (15mg/m2，i. e 5mg/m 2 ， was selected as the initial dose level for phase 1 clinical trials. |
回復(fù)此樓» 猜你喜歡
285求調(diào)劑
已經(jīng)有3人回復(fù)
-
求調(diào)劑
已經(jīng)有3人回復(fù)
-
招收博士1-2人
已經(jīng)有4人回復(fù)
-
08工科 320總分 求調(diào)劑
已經(jīng)有7人回復(fù)
-
生物學(xué)一志愿985，分?jǐn)?shù)349求調(diào)劑
已經(jīng)有7人回復(fù)
-
0856材料專碩353求調(diào)劑
已經(jīng)有4人回復(fù)
-
山東省面上項目限額評審
已經(jīng)有4人回復(fù)
-
一志愿北京化工大學(xué)070300 學(xué)碩336求調(diào)劑
已經(jīng)有5人回復(fù)
-
生物學(xué)071000 329分求調(diào)劑
已經(jīng)有4人回復(fù)
-
一志愿華中科技大學(xué)071000，求調(diào)劑
已經(jīng)有4人回復(fù)
2樓2014-09-17 16:24:57
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 小丸丸9 的主題更新
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料與化工（0856）304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-20 | 7/350 |
|
|---|---|---|---|---|
|
|
[考研] 278求調(diào)劑 +9 | 煙火先于春 2026-03-17 | 9/450 |
|
|
|
[考研] 296求調(diào)劑 +4 | www_q 2026-03-20 | 4/200 |
|
|
|
[考研] 277材料科學(xué)與工程080500求調(diào)劑 +6 | 自由煎餅果子 2026-03-16 | 6/300 |
|
|
|
[考研] 299求調(diào)劑 +5 | shxchem 2026-03-20 | 7/350 |
|
|
|
[考研] 316求調(diào)劑 +6 | 梁茜雯 2026-03-19 | 6/300 |
|
|
|
[考研] 307求調(diào)劑 +3 | wyyyqx 2026-03-17 | 3/150 |
|
|
|
[考研] 265求調(diào)劑 +3 | Jack?k?y 2026-03-17 | 3/150 |
|
|
[考研] 華東師范大學(xué)-071000生物學(xué)-293分-求調(diào)劑 +3 | 研究生何瑤明 2026-03-18 | 3/150 |
|
|
|
[考研] 304求調(diào)劑 +6 | 曼殊2266 2026-03-18 | 6/300 |
|
|
|
[考研] 一志愿西南交大，求調(diào)劑 +5 | 材化逐夢人 2026-03-18 | 5/250 |
|
|
|
[考研] 274求調(diào)劑 +10 | S.H1 2026-03-18 | 10/500 |
|
|
|
[考研]
 295復(fù)試調(diào)劑
+8
|
簡木ChuFront 2026-03-19 | 8/400 |
|
|
|
[考研] 材料工程專碩調(diào)劑 +5 | 204818@lcx 2026-03-17 | 6/300 |
|
|
|
[考研]
 0854，計算機類招收調(diào)劑
+3
|
胡辣湯放糖 2026-03-15 | 6/300 |
|
|
|
[考研] 材料，紡織，生物（0856、0710），化學(xué)招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|
|
|
[考研] 301求調(diào)劑 +4 | A_JiXing 2026-03-16 | 4/200 |
|
|
|
[考研] 東南大學(xué)364求調(diào)劑 +5 | JasonYuiui 2026-03-15 | 5/250 |
|
|
|
[考研] 318求調(diào)劑 +3 | Yanyali 2026-03-15 | 3/150 |
|
|
|
[考研] 321求調(diào)劑 +5 | 大米飯！ 2026-03-15 | 5/250 |
|